Shares Of ImmunoGen Down On Morgan Stanley's Bearish Initiation

By: via Benzinga
Citing “no upside driver beyond Kadcyla,” Morgan Stanley initiated coverage on ImmunoGen (NASDAQ: IMGN) with an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.